Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction
Clinical trial NCT04884243 · COMPLETED
Trial details
- NCT number
- NCT04884243
- Sponsor
- Cloudbreak Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-05
- Primary completion
- 2023-08-17
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.